{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2016", "item": "https://www.patentleaderboard.com/2016/"}, {"@type": "ListItem", "position": 3, "name": "Acceleron Pharma", "item": "https://www.patentleaderboard.com/2016/company/acceleron-pharma"}, {"@type": "ListItem", "position": 4, "name": "John Knopf", "item": "https://www.patentleaderboard.com/2016/inventor/fl:jo_ln:knopf-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
JK

John Knopf — 6 Patents in 2016

APAcceleron Pharma: 6 patents #2 of 7Top 30%
Edgartown, MA: #1 of 3 inventorsTop 35%
Massachusetts: #327 of 12,163 inventorsTop 3%
Overall (2016): #19,245 of 481,213Top 4%
6 Patents 2016

Issued Patents 2016

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
9526759 Activin-actriia antagonists and uses for treating or preventing breast cancer Jasbir Seehra, Ravindra Kumar 2016-12-27 $14,622,000
9480742 Method of promoting bone growth by an anti-actriia antibody Jasbir Seehra 2016-11-01 $13,053,000
9452197 Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof Jasbir Seehra, Robert Scott Pearsall, Asya Grinberg, Ravindra Kumar 2016-09-27 $18,543,000
9399669 Variants derived from ActRIIB Jasbir Seehra, Ravindra Kumar 2016-07-26 $18,094,000
9353356 Activin-actriia antagonists for treating a follicle-stimulating horomone-secreting pituitary tumor Jasbir Seehra, Matthew L. Sherman 2016-05-31 $19,296,000
9255137 Methods of promoting fat loss comprising administering an ALK7 inhibitor Jasbir Seehra 2016-02-09 $11,815,000